We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $1.67B
1-Year Est. Return 7.53%
This Fund
S&P 500
This Quarter Est. Return
-12.59%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
–
AUM
$6.47B
AUM Growth
-$1.17B
Cap. Flow
+$229M
Cap. Flow %
3.54%
Top 10 Hldgs %
71.2%
Holding
88
New
3
Increased
8
Reduced
7
Closed
12

Top Buys

Rank Stock Value
1
SE icon
Sea Limited
SE
+$271M
2
CRM icon
Salesforce
CRM
+$190M
3
LI icon
Li Auto
LI
+$121M
4
YSG
Yatsen Holding
YSG
+$113M
5
ENFN
Enfusion, Inc.
ENFN
+$101M

Top Sells

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$205M
2
BEAM icon
Beam Therapeutics
BEAM
+$126M
3
BABA icon
Alibaba
BABA
+$106M
4
ILMN icon
Illumina
ILMN
+$68M
5
BILI icon
Bilibili
BILI
+$42.2M

Sector Composition

Rank Sector Weight
1 Healthcare 48.41%
2 Consumer Discretionary 29.78%
3 Technology 11.51%
4 Communication Services 4.08%
5 Consumer Staples 3.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CIH
76
DELISTED
China Index Holdings Limited American Depository Shares
CIH
$291K ﹤0.01%
300,000
– –
AMD icon
77
Advanced Micro Devices
AMD
$700B
– –
-70,000
Closed -$7.2M
BABA icon
78
Alibaba
BABA
$276B
– –
-713,400
Closed -$106M
BEAM icon
79
Beam Therapeutics
BEAM
$2.68B
– –
-1,448,161
Closed -$126M
BILI icon
80
Bilibili
BILI
$7.75B
– –
-638,038
Closed -$42.2M
ILMN icon
81
Illumina
ILMN
$29.5B
– –
-172,307
Closed -$68M
KDP icon
82
Keurig Dr Pepper
KDP
$42.8B
– –
-284,792
Closed -$9.73M
KRON
83
DELISTED
Kronos Bio
KRON
– –
-153,698
Closed -$3.22M
LYEL icon
84
Lyell Immunopharma
LYEL
$318M
– –
-117,448
Closed -$34.8M
PACB icon
85
Pacific Biosciences
PACB
$435M
– –
-911,039
Closed -$23.3M
CDAK
86
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
– –
-142,978
Closed -$2.33M
CVET
87
DELISTED
Covetrus, Inc. Common Stock
CVET
– –
-155,124
Closed -$2.81M
CCCS.WS
88
DELISTED
CCC Intelligent Solutions Holdings Inc. Redeemable warrants, each whole warrant exercisable for one
CCCS.WS
– –
-40,000
Closed -$93K
1 2 3
4

Similar funds

TFS
Thoroughbred Financial Services Brentwood, Tennessee $1.67B AUM 37.77% 1-Year Est. Return
GC
Garde Capital Seattle, Washington $1.67B AUM 13.9% 1-Year Est. Return
PA
Proem Advisors Dallas, Texas $1.68B AUM 199.97% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
NRI
NFP Retirement Inc Aliso Viejo, California $1.67B AUM 13.03% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return

HHLR Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, HHLR Advisors held 88 positions worth $6.47B, down 15% from $7.65B the previous quarter. Its ten largest holdings account for 71% of the portfolio.

HHLR Advisors deployed $229M of net new capital in Q4 2021, opening 3 new positions and adding to 8 existing holdings. Its largest new stake was Enfusion, Inc.: 4,975,183 shares worth $104M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 58% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Pinduoduo, an estimated $205M trimmed.

  • HHLR Advisors's largest Q4 2021 buy was Enfusion, Inc.: 4,975,183 shares worth $104M.
  • HHLR Advisors added most to Sea Limited in Q4 2021, an estimated $271M increase.
  • HHLR Advisors's biggest Q4 2021 reduction was Pinduoduo, cutting an estimated $205M.
  • HHLR Advisors fully exited Beam Therapeutics in Q4 2021, selling an estimated $126M.
  • HHLR Advisors's ten largest holdings make up 71% of its $6.47B portfolio in Q4 2021.
  • HHLR Advisors opened 3 new positions and closed 12 in Q4 2021.
  • HHLR Advisors's portfolio value fell 15% quarter-over-quarter to $6.47B.

Based on HHLR Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.